Mannose-binding protein
Human serum contains mannose-binding protein (MBP), a calcium-dependent C-type lectin, secreted by hepatocytes, which binds glycoproteins terminating in mannose or N-acetylglucosamine. MRP occurs in serum as a mixture of oligomers of 9-18 identical polypeptide chains of 32 kDa [I-51. On binding to a mannose-rich surface, MRP activates complement through the classical pathway [6] . MRP binds C l r and Cls to form C1 esterase, which cleaves C2 and C4, which in turn form a complex on the mannose-rich surface to form C 3 convertase. C3 convertase cleaves C 3 to form C3b which then binds to the surface and opsonizes the ligand. Recently MBP has been shown to be identical with Ra-reactive factor [7] . Ra-reactive factor is a complement-activating bactericidal protein which binds to Ra-chemotype strains of bacteria and yeasts.
MRP is encoded by four exons each of which code for different functional domains of the molecule [8, 9] . Exon 1 encodes the signal sequence of a secreted protein, a cysteine-rich domain and seven copies of the motif Gly-Xaa-Yaa, which is typical of a collagen domain. The junction between exon 1 and exon 2 encodes the sequence Gly-Gln-Gly.
Exon 2 encodes a further 12 Gly-Xaa-Yaa collagen repeats. Exon 3 encodes a short 'neck' domain and exon 4, the largest exon, encodes the carbohydratebinding domain.
The structure of the high-molecular-weight oligomers of MBP that are found in serum can be inferred from the sequence of the MBP gene. Trimers of MBP polypeptides associate by forming Abbreviation used: MHI', mannose-binding protein.
a triple helix between their collagen domains. The interruption of the collagen motif by the sequence Gly-Gln-Gly between exons 1 and 2, by analogy with Clq, is probably the site where the triple-helical chains of MBP appear to bend on electronmicroscopy [ 101. The triple helices are stabilized by disulphide bridges between the cysteine-rich domains. Three to six of the trimers assemble by disulphide bridges into oligomers. This gives the final MBP oligomer the appearance of a bunch of flowers, where the flower heads are the carbohydrate-binding domains and the stalks are the collagen domains.
MBP is an acute phase protein [8, 113 . The 5' flanking sequence of the MBP gene contains a heatshock-promoter sequence and two glucocorticoidresponsive promoter sequences typical of acute phase protein genes.
Immunodeficiency caused by defective opsonization
Infants of 6-18 mth with this immunodeficiency syndrome suffer repeated bacterial and fungal infections [ 12, 131. The immunodeficiency is present in about 25% of children with frequent unexplained infections. Children with the defect suffer about twice as many severe infections as matched control children [ 141. The infections may be severe and five deaths have been reported. Usually relatives of the immunodeficient infants suffered repeated infections while infants. There is a high frequency of atopy in the children and their families [14] . This immunodeficiency is common with an estimated frequency, judged by tests of opsonic function, of 5-7% [13, 15, The laboratory findings are characteristic; in vitro, normal polymorphonuclear leucocytes incubated with serum from patients do not phagocytose bacteria or yeasts. The defect is corrected by the addition of heterologous serum, indicating that the serum of the patient lacks an opsonin which is essential for phagocytosis. Furthermore, intravenous infusions of fresh frozen plasma correct the opsonization defect in affected infants [ 131. Complement levels are normal in the patients. In the first report of this immunodeficiency syndrome it was shown that the opsonization defect was also present in the mother and the maternal grandparents but was not present in the father [ 121, clearly showing that the syndrome is caused by an inherited deficiency.
Association of defective opsonization with mannose-binding protein deficiency
Experiments were performed to characterize the deficient opsonin. An association between the opsonic defect and the deposition of low amounts of the complement components C3b/C3bi on the surface of yeast has been reported [17] . It has been shown that this antibody-independent cleavage of complement occurred when serum was incubated with mannan and that the opsonin mediating the effect was MBP [18] . Further, it has been reported that ten children with recurrent infections due to defective opsonization had very low serum MBP levels and that their opsonic defect could be corrected in vitro by the addition of purified MBP to serum [ 191.
Molecular basis of defective opsonization
T o determine the basis of this immunodeficiency syndrome, the MBP gene structure was analysed in three families with affected children [20] . Each proband had suffered from recurrent bacterial infections up to age 14 mth, including recurrent upper respiratory tract infections and otitis media (two patients) and meningococcal septicaemia (one patient). All had the opsonic defect and low serum MBP levels. Genomic DNA was isolated from whole blood and the four exons which encode MBP were amplified by asymmetric PCR [21] and sequenced with a complementary primer. The complete nucleotide sequence of the exons was determined in two probands and the sequence of exon 1 was determined in a further 16 family members. Figure 1 shows that autosomal dominant inheritance fits the transmission of low serum MBP levels in the three families best. In the three probands the sequence showed a point mutation at base 230 of exon 1 causing a change of codon 54 from GGC to GAC, resulting in the substitution of aspartic acid for glycine at this position. The family Volume 21 members could be classified into three genotypes; homozygous Gly/Gly, heterozygous Gly/Asp and homozygous Asp/Asp. All 14 family members with low serum MBP levels were either heterozygous or homozygous for the aspartic acid substitution at codon 54.
The mean serum MBP concentration in the five Gly/Gly homozygotes was 1680 f 250 ng/ml (mean k S.E.M.), in the nine Gly/Asp heterozygotes, 150 k 80 ng/ml and in the five Asp/Asp homozygotes, 19k 8 ng/ml. It is clear that the mutation profoundly lowers serum MBP levels even in heteroz ygotes. The way that this collagen domain mutation reduces serum MBP levels is probably analogous to the mechanism of osteogenesis imperfecta. The mutation in codon 54 replacing glycine with aspartic acid disrupts the fifth Gly-Xaa-Yaa repeat in exon 1 of the MBP gene. In osteogenesis imperfecta mutations of homologous axial glycine residues result in the failure of collagen polymerization [22] . This is because in the helical coils of collagen only the glycine residues, which occur every third amino acid, are small enough to pack into the axial positions. Of the many mutations found in osteogenesis imperfecta, substitution of glycine with aspartic acid is most disruptive of polymerization and causes the most severe clinical syndrome, probably because aspartic acid is not only large, but also charged. Thus the mutation in the MBP gene by analogy may result in low serum MBP levels because of the failure of the abnormal MBP subunits to polymerize into functional oligomers. Consequently in heterozygotes low serum MBP levels would be expected since only one in eight of the trimers would not be disrupted by mutant polypeptide chains. A recent study confirms that the codon 54 mutation causes a profound lowering of serum MBP levels [23] , but paradoxically reports that the mutant subunits, produced by an in vitro expression system, appear to assemble into oligomers. These mutant MBP oligomers were unstable and could not activate complement. It seems probable that this discrepancy between in vivo and in vitro observations indicates simply that the mouse hybridoma expression system is not a good physiological model of the human hepatocyte.
How common is the codon 54 MBP mutation?
The frequency of the codon 54 mutation has now been determined in populations of British, Chinese and Gambian normal subjects [24, 251 and is common in British Caucasians and in Chinese. In 98 British Caucasians the mutant gene frequency was 0.17 and in 123 Chinese, 0.1 1. No homozygous mutant individuals were found in these 221 subjects and the proportions of wild type and heterozygous individuals approximated to the expected HardyWeinberg distributions. The median serum MBP concentrations in heterozygote British and Chinese was about 116 of the median values in wild-type subjects. Similar data have been obtained from a population of Danish blood donors, where 2/ 123 subjects were homozygous for the mutation [26] . These results indicate that in Caucasian and Oriental populations about 24% will be heterozygous for the codon 54 mutation and confirm the profound effect that the mutation has on serum MHP levels. Furthermore the absence of homozygous mutant individuals in the normal British Caucasian and Chinese subjects contrasts with the three families with the opsonization defect, where 20% were homozygous mutants [20] .
Surprisingly the codon 54 mutation was present in only 11199 Gambians (mutant gene frequency 0.003). The HLA DR haplotype patterns of the subject with the mutation were those found in this population usually (DR BI* 1304/1302) and did not indicate a recent admixture of Caucasian genes.
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A new MBP mutation at codon 57 in Africans
When Gambian serum MBP levels in the previous group were assayed, 24 subjects were identified in whom the protein was undetectable ( < 10 ng/ml). Nucleotide sequencing in these subjects revealed a new MBP point mutation at codon 57 (GGA to GAA). This results in a glycine to glutamic acid substitution which, by disrupting the sixth Gly-XaaYaa repeat in exon 1, was expected to resemble the codon 54 mutation in its effect on secondary protein structure.
Genetic analysis was performed either by sequencing exon 1 or by restriction analysis in adult Gambian blood donors (n = 100) and newborns (n = 99), since the codon 57 mutation introduces an MboII restriction site between bases 250 and 251. The codon 57 mutation is very common in Gambians; in newborns the mutant gene frequency was 0.23 and in adults, 0.29. The distribution of genotypes in newborns was similar to HardyWeinberg distributions, but in adults they were significantly different (x' = 8.7, P < 0.02) for reasons that have not been established. Thus in Gambians about 29% are heterozygous and 12% are homozygous for the codon 57 mutation. This mutation disrupts serum MBP levels in a similar fashion to the codon 54 mutation in Caucasians and Chinese (Table 1) . Serum MB was undetectable in all Gambians who were homozygous for the codon 57 mutation. The median serum MBP level in heterozygous Gambians (1 86 ng/ml) was about 10% of the median level in wild-type Gambians (1 9 15 ng/ml) (P < 0.000 1).
Evolutionary and biological significance of MBP mutations
These data for MBP mutations fit readily into one of the current models of recent human evolution, which draws on relationships between genomic DNA patterns in various populations and points to a separation between the ancestors of modern African and non-African peoples about 100 000 years ago. Chinese and European peoples appear to have diverged at about 40000 BP although gene flow across Asia probably occurred [27-301. Thus the presence of the codon 54 mutation in British, Danish and Chinese people at similar frequencies suggests that this mutation arose more than 40000 years ago. If the presence of the codon 54 mutation in a single Gambian does not reflect recent gene admixture the mutation may be much older. The maintenance of the mutant codon 54 allele over such a long period suggests that it confers some biological advantage and the presence of a different MBP mutation in Gambians at even higher frequency supports this view further.
What biological advantage could a mutation have which causes a susceptibility to infantile infections? It is possible that the main role of MBP in host defence is during the first 6-18 mth of life, when maternal antibodies have disappeared but before the antibody repertoire of the infant has developed. However, throughout life MBP would retain the capacity to activate complement following binding to mannose-rich micro-organisms. Thus the increased susceptibility to paediatric infection of a small number of subjects with homozygous MBP mutations may be outweighed by a reduced capacity for complement activation and immunemediated host damage in subjects bearing one mutant allele. This hypothesis is consistent with data indicating that African patients with complement deficiencies have a lower mortality from meningococcal infections [ 3 13 and a lower incidence of septicaemic shock [32] . In the relatively hostile infectious environment of Africa, deletion of MBP-mediated complement activation, by reducing immune-mediated host damage, may be an advantage and could account for the high frequency of the mutant allele in this population.
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